Application no. and date | 14713844.0 (espacenet) (Federated) (European Patent Register), 20140328 | Patent/reg. no. and date | DK/EP 2948455, 20170927 | Publication date | 20151202 | Priority no. and date | EP 13161863, 20130329, EP 13193025, 20131115, EP 14154303, 20140207 | EP pub. no. and date |
EP 2948455 20151202 | Effective date | | Applicant/owner | Ogeda NV, Medialaan 50
1800 Vilvoorde
, BE | Applicant ref. no. | V1710-038-DK | Inventor | DUTHEUIL, Guillaume, Rue Joseph Debehogne 19
B-5020 Vedrin, BE, FRASER, Graeme, Rue Bois des Conins 19A
B-1470 Bousval, BE, HOVEYDA, Hamid, Rue Meyerbeer 72
B-1190 Bruxelles, BE | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/4985 (2006.01) , A61P 25/00 (2006.01) , A61P 29/00 (2006.01) , C07D 487/04 (2006.01) | Title | N-ACYL-(3-SUBSTITUEREDE)-(8-SUBSTITUEREDE)-5,6-DIHYDRO-[1,2,4]TRIAZOL[4,3-A]PYRAZINER SOM SELELTIVE NK-3-RECEPTORANTAGONISTER, FARMACEUTISK SAMMENSÆTNING, FREMGANGSMÅDER TIL ANVENDELSE I NK-3 RECEPTOR-MEDIEREDE FORSTYRRELSER | Int. application no. | EP2014056367 | Int. publication no. | WO2014154895 | Related patent (certificate) | CA 2024 00017 | Status | Rettet DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|